Flexion Therapeutics Inc. (FLXN)

Sector:Health Care
Super Investor Stats:
Ownership count:0
Ownership rank:--
% of all portfolios:0%
History Portfolio Manager Activity ▼ Share change % change to portfolio
Q4  2021
≡ First Eagle Investment Management Sell 100.00% 38,841 0.00
Q3  2021
≡ First Eagle Investment Management Add 366.17% 30,509 0.00
Q2  2021
≡ First Eagle Investment Management Buy 8,332 0.00
≡ Bill Miller - Miller Value Partners Sell 100.00% 4,101,735 1.04
Q1  2021
≡ Bill Miller - Miller Value Partners Reduce 2.25% 94,365 0.02
Q4  2020
≡ Bill Miller - Miller Value Partners Reduce 20.44% 1,078,339 0.42
Q3  2020
≡ Bill Miller - Miller Value Partners Add 1.52% 78,889 0.03
Q2  2020
≡ Bill Miller - Miller Value Partners Add 22.55% 956,081 0.56
Q1  2020
≡ Bill Miller - Miller Value Partners Reduce 14.06% 693,406 0.35
Q4  2019
≡ Bill Miller - Miller Value Partners Reduce 5.42% 282,935 0.21
Q3  2019
≡ Bill Miller - Miller Value Partners Add 7.49% 363,350 0.20
Q2  2019
≡ Bill Miller - Miller Value Partners Add 18.07% 742,740 0.37
Q1  2019
≡ Bill Miller - Miller Value Partners Add 32.00% 996,330 0.50
Q4  2018
≡ Bill Miller - Miller Value Partners Add 8.06% 232,190 0.12
Q3  2018
≡ Bill Miller - Miller Value Partners Add 8.57% 227,425 0.14
Q2  2018
≡ Bill Miller - Miller Value Partners Reduce 0.60% 16,125 0.02
Q1  2018
≡ Bill Miller - Miller Value Partners Reduce 0.54% 14,600 0.01
Q4  2017
≡ Bill Miller - Miller Value Partners Add 127.24% 1,503,175 1.65
Q3  2017
≡ Bill Miller - Miller Value Partners Add 123.82% 653,525 0.74
Q2  2017
≡ Bill Miller - Miller Value Partners Buy 527,800 0.49

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.